Tolera Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tolera.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
Phase 1
- Conditions
- Renal TransplantEnd Stage Renal Disease
- Interventions
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- Tolera Therapeutics, Inc
- Target Recruit Count
- 85
- Registration Number
- NCT01154387
- Locations
- 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
News
No news found